<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11859543</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1180</article-id><article-id pub-id-type="other">EPV0484</article-id><article-id pub-id-type="pii">S0924933824011805</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Towards an increased attention on ADHD symptoms and traits in young adults: prevalence data from screening tools in a psychiatric outpatient clinic</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sanguineti</surname><given-names>C.</given-names></name><xref rid="aff2662" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Nistico&#x02019;</surname><given-names>V.</given-names></name><xref rid="aff2662" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2663" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff2664" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Folatti</surname><given-names>I.</given-names></name><xref rid="aff2662" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Santangelo</surname><given-names>G.</given-names></name><xref rid="aff2662" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Faggioli</surname><given-names>R.</given-names></name><xref rid="aff2665" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bertani</surname><given-names>A.</given-names></name><xref rid="aff2666" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gambini</surname><given-names>O.</given-names></name><xref rid="aff2662" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2664" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff2665" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Demartini</surname><given-names>B.</given-names></name><xref rid="aff2664" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff2664" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff2665" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff2665" ref-type="aff">
<sup>4</sup>
</xref><xref rid="cor1034" ref-type="corresp">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="aff2662"><sup>1</sup>Health Science Department, <institution>University of Milan</institution></aff><aff id="aff2663"><sup>2</sup>Department of Psychology, <institution>University of Milan Bicocca</institution></aff><aff id="aff2664">
<sup>3</sup>
<institution>Aldo Ravelli Research Center for Neurotechnology and Experimental Brain Therapeutics, University of Milan</institution>
</aff><aff id="aff2665"><sup>4</sup>UO Psichiatria 51 e 52</aff><aff id="aff2666"><sup>5</sup><institution>Centro Giovani Ettore Ponti, ASST Santi Paolo e Carlo</institution>, Presidio San Paolo, <city>Milan</city>, <country>Italy</country></aff><author-notes><corresp id="cor1034"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1155">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S567</fpage><lpage>S567</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824011805a.pdf"/><abstract><sec id="sec6216"><title>Introduction</title><p>Attention&#x02013;Deficit/Hyperactivity Disorder (ADHD) is a heterogeneous neurodevelopmental disorder encompassing developmentally inappropriate inattentiveness, hyperactivity, and increased impulsivity (DSM-5). Symptoms presentation is different for different stages of life; moreover, individuals with ADHD symptomatology can develop abilities and strategies that help them adapt and mask the distinctive features of the condition, thus reducing the functional impairment usually seen in ADHD subjects, and ultimately not receiving neither a clinical diagnosis nor a proper therapeutic support. They might express their lack of well-being through other transdiagnostic symptoms, and finally reach psychiatric attention for potential comorbidities. Hence, it was argued that the existence of children and adolescents with subthreshold and underrecognized symptoms that subsequently develop into a full diagnosis suggests that ADHD should be significantly more considered in adult mental health settings.</p></sec><sec id="sec6217"><title>Objectives</title><p>Here we aimed to analyse the prevalence of ADHD symptoms and traits in a heterogeneous clinical psychiatric sample of young adults (aged 18 to 24 years old), who referred to a specialized outpatient clinic for various psychiatric and psychological disturbances.</p></sec><sec id="sec6218"><title>Methods</title><p>259 participants completed three validated self-report screening questionnaires for ADHD: the Wender Utah Rating Scale (WURS), the Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5 (ASRS-5), and the Conners&#x02019; adult ADHD rating scale (CAARS).</p></sec><sec id="sec6219"><title>Results</title><p>12.4% of our sample scored above the cut-off at both the WURS and the ASRS-5 and was considered at risk of ADHD.</p></sec><sec id="sec6220"><title>Conclusions</title><p>
The prevalence rate in our sample is higher than the one found in the adult general population (6.76%), and in the lower range of the one found in the adult clinical population (6.9% to 38.8%). We discuss the potential role of sociodemographics (age, sex, gender identity, and employment) and comorbidity factors. Differences in the clinical presentation of ADHD according to sex assigned at birth and age should be considered during every psychiatric evaluation to minimize the risk of underdiagnosis. We advocate for further studies investigating the prevalence of ADHD in different psychiatric services for adults, and for a stronger presence of specialistic ADHD services and trained clinicians on the territory: this would increase diagnostic reliability, consequently providing a better treatment for ADHD in adults, and facilitate the transition from pediatric to adult&#x02019;s services.</p></sec><sec id="sec6221"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>